EchoS

A new era in bone densitometry

Innovative radiation-free solution for assessing the bone condition of lumbar vertebrae and femoral neck with a quick scanning using proprietary R.E.M.S. technology. Prevention, early diagnosis and monitoring of osteoporosis can be done directly from the medical clinic right from today.

R.E.M.S. Technology

R.E.M.S. in the guidelines.

Developed by a committee coordinated by the Italian National Institute of Health (ISS), guided by prestigious Scientific Organisations and Clinical Bodies, the “Diagnosis, risk stratification and continuity of care for Fragility Fractures” guidelines are the most advanced recommendations of good clinical practice for fragility fracture risk assessment.

Osteoporosis

A new concept of bone health

This marks the beginning of new way of managing assessment of bone condition through prevention, early diagnosis of osteoporosis, and monitoring of bone health in primary care, either comfortably in the clinic or directly in the patient’s bed at home.

Q

Radiation-free
Technology

Lumbar Vertebrae
Proximal Femur

Bone Density
Bone Quality

Patented
FDA Cleared

EchoS

A new concept of Bone Health

This marks the beginning of new way of managing assessment of bone condition through prevention, early diagnosis of osteoporosis, and monitoring of bone health in primary care, either comfortably in the clinic or directly in the patient’s bed at home.

News

HTA Study on REMS

HTA Study on REMS

​SDA Bocconi University: REMS helps cut NHS costs   According to the HTA independent research...

read more

Events

ARAB HEALTH 2022

ARAB HEALTH 2022

Echolight at the ARAB HEALTH TRADE SHOW. Echolight SpA is proud to invite you to the Arab Health...

read more

Research

FDA Approved

The most advanced bone densitometer for bone health assessment for your daily clinical activities.

Through an ultrasound scan of axial anatomical sites such as the spine and femur, this innovative technology allows to measure bone mineral density without using ionising radiation, by processing a true bone identity card. Besides ensuring a high level of accuracy, it does not require radiological protection, it is easy to use and its distinctive transportability facilitates the use thereof among patients hospitalised with fractures who cannot be transferred and the continuity of care at home.
Furthermore, the absence of radiation allows this method to be used on a heterogeneous variety of patients, including paediatric patients, patients at risk of secondary osteoporosis, diabetic patients, patients who have undergone cancer treatments and pregnant women.

Q

EchoS

The most advanced bone densitometer for bone health assessment

Through an ultrasound scan of axial anatomical sites such as the spine and femur, this innovative technology allows to measure bone mineral density without using ionising radiation, by processing a true bone identity card. Besides ensuring a high level of accuracy, it does not require radiological protection, it is easy to use and its distinctive transportability facilitates the use thereof among patients hospitalised with fractures who cannot be transferred and the continuity of care at home.
Furthermore, the absence of radiation allows this method to be used on a heterogeneous variety of patients, including paediatric patients, patients at risk of secondary osteoporosis, diabetic patients, patients who have undergone cancer treatments and pregnant women.
.

Why Echos

Radiation-free

The first ultrasound system which allows access to prevention, early diagnosis of osteoporosis and monitoring through basic health care. EchoS can assess bone health conditions of people who have been discharged from hospital, using X-rays, by means of a simple ultrasound carried out directly at the pharmacy, at a private clinic or even at home.

Quick Scan

The ultrasound scan takes just 80 seconds for the spine and 40 seconds for the femur, therefore enabling an accurate prevention, diagnosis and monitoring of bone health without limitations relating to the positioning of the patient and manual image segmentation.

Report on the spot

The examination generates an instantaneous medical report which – besides including all parameters most commonly used in the diagnosis of osteoporosis such as BMD (g/cm2), T-score, Z-score – also includes independent assessment of internal bone structure, which provides a fragility index and body composition index.

Portable Solution

EchoS also comes in a portable version which allows to conduct examinations wherever one can connect the main unit to a laptop using a simple USB cable. The size and materials that make EchoS an ultra-light device allow an easy displacement thereof.

Cost Effective

EchoS does not require a qualified operator, a shielded room, and high maintenance costs. Its versatility of use anywhere and under any condition offers significant benefits to your clinic and your patients.

The science of excellence

As regards diagnosis of osteoporosis and related bone diseases, the most prestigious personalities of the world scientific community have chosen EchoS and share their thoughts on their experience using R.E.M.S. technology. The clinical validation of proprietary technology was carried out in the most prestigious centres of reference for the diagnosis of osteoporosis worldwide.

Prof. Maria Luisa Brandi

Director of the Bone Unit Careggi Hospital
Prof. di Endocrinology
Florence University

“Being radiation-free, Echos enables to diagnose osteoporosis for patients who had ruled out this type of test due to poor accessibility”.

Q

Prof. Jean-Yves Reginster

ESCEO President
Head of the bone metabolism Unit.
University of Liegi, Belgium.

“The first ultrasound device that is beneficial to patients in terms of diagnosis of osteoporosis. Innovative, accurate, precise

Q

Prof. Cyrus Cooper

IOF President
Professor of Reumatology
University of Southampton, UK

“Finally, a radiation-free technology with a very simple and quick but at the same time very accurate and reliable scanning.”

Q

The next generation of health care

Created as a spin-off of the Italian National Research Council, Echolight is at the forefront of medical innovation, introducing new cutting-edge solutions to contribute to human wellbeing. We have been awarded all the standard certificates: UNI CEI EN ISO 13485: 2016, Quality Management System UNI EN ISO 9001: 2015, CE mark, FDA approval and other major certificates worldwide for our innovative solutions.

Imagination. Know-how. Innovation.

Discover our Company

    Contact Us

    More info or book a demo.



    Position*

    *Required fields



    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Echolight S.p.a.

    Viale Cipro, 6
    73100 Lecce – Italy
    +39 0832 159 26 07

    US Headquarters
    509 Madison Ave RM 1510
    New York, New York 10022, USA
    +1-833-263-7367
    +1 425 658 0601

    Copyright © 2021 - Echolight S.p.a

    New HQ in New York City

    We are pleased to announce the move of our new USA Headquarters to the beating heart of the Big Apple, with offices located in a prestigious building in New York City and precisely at 509 Madison Avenue in the center of Manatthan.

    Click here